Stock 1786 SCIVISION BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases SciVision Biotech Inc.

Equities

1786

TW0001786002

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
108 TWD -1.37% Intraday chart for SciVision Biotech Inc. +3.85% +39.18%
Apr. 10 SciVision Biotech Inc.?s Products, Flexotron Solo (2.2%) and Flexotron Magnum (3%) Obtain Medical Device Licenses CI
Apr. 09 Scivision Biotech Inc.'s CREATEFILL Obtains Medical Device License of Class III Medical Devices CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds
PU
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds For 3 Months
PU
SciVision Biotech : Announcement of board meeting approved the consolidated financial statements for the second quarter of 2022
PU
SciVision Biotech : Announcement of the company's financial officer, accounting officer and corporate governance officer approved by Board of Directors.
PU
SciVision Biotech : Announce the record date for cash dividend
PU
SciVision Biotech : Announcement the Important Resolutions in 2022 Annual General Meeting of Shareholders
PU
SciVision Biotech : The Company’s Product, hyaluronic acid Flexotron Forte (1%) has obtained medical device license.
PU
SciVision Biotech : The The Company’s Product, hyaluronic acid three-injection linear intra-articular implant, Flexotron Plus (2%) has obtained medical device license.
PU
SciVision Biotech : Board of Directors approved the convening of the 2022 Annual Shareholders' Meeting
PU
SciVision Biotech : The Company's Board of Directors resolved the dividend distributions
PU
SciVision Biotech : The Company's 2021 consolidated financial statements have been approved by the Board of Directors
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1786 Stock
  4. News SciVision Biotech Inc.
  5. Press Releases